Skip to content

The Impact of Esmolol Administration on Postoperative Recovery

Unknown statusNot applicableNCT05567822
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The aim of this study will be to investigate the effect of a continuous infusion of low dose esmolol on intraoperative and postoperative opioid consumption, as well as on postoperative recovery and chronic pain

Study details

Official title
The Effect of Intraoperative Esmolol Administration on Postoperative Recovery and Chronic Pain
Conditions
Interventions
Sponsor
Aretaieion University Hospital
Start date
2022-10-01
Primary completion
2024-10-01
Sex
All
Age range
from 18 Years to 75 Years
Results posted
No results posted in this snapshot
Countries
Greece
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * adult patients * American Society of Anesthesiologists (ASA) classification I-II * elective inguinal hernia repair Exclusion Criteria: * body mass index (BMI) \>35 kg/m2 * β-blocker administration preoperatively * systematic use of analgesic agents preoperatively * chronic pain syndromes preoperatively * neurological or psychiatric disease on treatment * pregnancy * severe hepatic or renal disease * history of cardiovascular diseases/ arrhythmias/ conduction abnormalities * hemodynamic instability * drug or alcohol abuse * language or communication barriers * lack of informed consent * bilateral inguinal hernia repair

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05567822